{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:17:04Z","timestamp":1789503424020,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012155","name":"National Institute for Medical Research Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","award":["NIMAD 958012"],"award-info":[{"award-number":["NIMAD 958012"]}],"id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.micpath.2025.107894","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T15:20:46Z","timestamp":1752592846000},"page":"107894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Enhancing Mycobacterium tuberculosis-Ag85B immunogenicity by fusing with human Fc\u03b31 (Ag85B:hFc\u03b31)"],"prefix":"10.1016","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1194-3325","authenticated-orcid":false,"given":"Hamid","family":"Bahrami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8408-4664","authenticated-orcid":false,"given":"Arman","family":"Mosavat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Soleimanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Farsiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narges","family":"Valizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6814-5992","authenticated-orcid":false,"given":"Seyed Abdolrahim","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas Ali","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"629","key":"10.1016\/j.micpath.2025.107894_bib1","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/ej\/ueaa014","article-title":"Preventing the white death: tuberculosis dispensaries","volume":"130","author":"Egedes\u00f8","year":"2020","journal-title":"Econ. J."},{"issue":"1","key":"10.1016\/j.micpath.2025.107894_bib2","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/imr.12269","article-title":"The human immune response to tuberculosis and its treatment: a view from the blood","volume":"264","author":"Cliff","year":"2015","journal-title":"Immunol. Rev."},{"issue":"7","key":"10.1016\/j.micpath.2025.107894_bib3","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2174\/1389201021666200730143906","article-title":"HIV-tuberculous meningitis co-infection: a systematic review and meta-analysis","volume":"22","author":"Purmohamad","year":"2021","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.micpath.2025.107894_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejmech.2015.07.039","article-title":"Linked pyridinyl-thiadiazoles: design and synthesis as potential candidate for treatment of XDR and MDR tuberculosis","volume":"102","author":"Mahajan","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.micpath.2025.107894_bib5","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/1469-0691.12253","article-title":"The re-emergence of tuberculosis: what have we learnt from molecular epidemiology?","volume":"19","author":"Borgdorff","year":"2013","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.micpath.2025.107894_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117594","article-title":"Tuberculosis vaccine: a journey from BCG to present","volume":"252","author":"Fatima","year":"2020","journal-title":"Life Sci."},{"issue":"Pt A","key":"10.1016\/j.micpath.2025.107894_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ijbiomac.2018.08.037","article-title":"Novel vaccine candidates against Mycobacterium tuberculosis","volume":"120","author":"Khoshnood","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.micpath.2025.107894_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijid.2016.10.018","article-title":"Novel approaches to tuberculosis vaccine development","volume":"56","author":"Kaufmann","year":"2017","journal-title":"Int. J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.micpath.2025.107894_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.micpath.2025.107894_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.micpath.2017.08.040","article-title":"Antigen 85 complex as a powerful Mycobacterium tuberculosis immunogene: biology, immune-pathogenicity, applications in diagnosis, and vaccine design","volume":"112","author":"Babaki","year":"2017","journal-title":"Microb. Pathog."},{"issue":"1","key":"10.1016\/j.micpath.2025.107894_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/viru.22329","article-title":"Virulence factors of the Mycobacterium tuberculosis complex","volume":"4","author":"Forrellad","year":"2013","journal-title":"Virulence"},{"issue":"4","key":"10.1016\/j.micpath.2025.107894_bib12","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1128\/mr.56.4.648-661.1992","article-title":"The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis","volume":"56","author":"Wiker","year":"1992","journal-title":"Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.micpath.2025.107894_bib13","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1074\/jbc.M111.298687","article-title":"Novel mycobacteria antigen 85 complex binding motif on fibronectin","volume":"287","author":"Kuo","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.micpath.2025.107894_bib14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.tube.2017.10.007","article-title":"I3-Ag85 effect on phthiodiolone dimycocerosate synthesis","volume":"108","author":"Rens","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.micpath.2025.107894_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fimmu.2014.00321","article-title":"The immunodominant T-Cell epitopes of the mycolyl-transferases of the antigen 85 complex of M. tuberculosis","volume":"5","author":"Huygen","year":"2014","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.micpath.2025.107894_bib16","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/j.1462-5822.2007.00884.x","article-title":"The Ag85B protein of Mycobacterium tuberculosis May turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice","volume":"9","author":"Palma","year":"2007","journal-title":"Cell. Microbiol."},{"issue":"10","key":"10.1016\/j.micpath.2025.107894_bib17","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/icb.2012.34","article-title":"HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule","volume":"90","author":"Taylor","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"10.1016\/j.micpath.2025.107894_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108791","article-title":"A century of attempts to develop an effective tuberculosis vaccine: why they failed?","volume":"109","author":"Soleimanpour","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.micpath.2025.107894_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/imr.13379","article-title":"Living in LALA land? Forty years of attenuating Fc effector functions","author":"Hale","year":"2024","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.micpath.2025.107894_bib20","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3109\/07388551.2016.1163323","article-title":"Fc\u03b31 fragment of IgG1 as a powerful affinity tag in recombinant Fc-fusion proteins: immunological, biochemical and therapeutic properties","volume":"37","author":"Soleimanpour","year":"2017","journal-title":"Crit. Rev. Biotechnol."},{"issue":"10","key":"10.1016\/j.micpath.2025.107894_bib21","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/emmm.201201379","article-title":"Fc-fusion proteins: new developments and future perspectives","volume":"4","author":"Czajkowsky","year":"2012","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.micpath.2025.107894_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.tibtech.2014.11.001","article-title":"Fc fusion as a platform technology: potential for modulating immunogenicity","volume":"33","author":"Levin","year":"2015","journal-title":"Trends Biotechnol."},{"issue":"10","key":"10.1016\/j.micpath.2025.107894_bib23","first-page":"1324","article-title":"Game theory applications in host-microbe interactions toward disease manifestation: mycobacterium tuberculosis infection as an example","volume":"24","author":"Sharebiani","year":"2021","journal-title":"Iran J. Basic Med. Sci."},{"issue":"7","key":"10.1016\/j.micpath.2025.107894_bib24","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1039\/C6MB00174B","article-title":"Fc-based delivery system enhances immunogenicity of a tuberculosis subunit vaccine candidate consisting of the ESAT-6:CFP-10 complex","volume":"12","author":"Farsiani","year":"2016","journal-title":"Mol. Biosyst."},{"issue":"5","key":"10.1016\/j.micpath.2025.107894_bib25","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00284-024-03655-3","article-title":"Production and evaluation of Ag85B:HspX:hFc\u03b31 immunogenicity as an Fc fusion recombinant multi-stage vaccine candidate against Mycobacterium tuberculosis","volume":"81","author":"Karbalaei","year":"2024","journal-title":"Curr. Microbiol."},{"issue":"9","key":"10.1016\/j.micpath.2025.107894_bib26","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s11033-016-4024-9","article-title":"Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis","volume":"43","author":"Kebriaei","year":"2016","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.micpath.2025.107894_bib27","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.meegid.2016.01.027","article-title":"Fused Mycobacterium tuberculosis multi-stage immunogens with an Fc-delivery system as a promising approach for the development of a tuberculosis vaccine","volume":"39","author":"Mosavat","year":"2016","journal-title":"Infect. Genet. Evol."},{"issue":"24","key":"10.1016\/j.micpath.2025.107894_bib28","doi-asserted-by":"crossref","first-page":"10467","DOI":"10.1007\/s00253-015-6952-z","article-title":"APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice","volume":"99","author":"Soleimanpour","year":"2015","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.micpath.2025.107894_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2023.108283","article-title":"Influence of glycosylation on the immunogenicity and antigenicity of viral immunogens","volume":"70","author":"Newby","year":"2024","journal-title":"Biotechnol. Adv."},{"issue":"24","key":"10.1016\/j.micpath.2025.107894_bib30","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1093\/nar\/25.24.4876","article-title":"The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools","volume":"25","author":"Thompson","year":"1997","journal-title":"Nucleic Acids Res."},{"issue":"9","key":"10.1016\/j.micpath.2025.107894_bib31","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/prot.22570","article-title":"Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8","volume":"77","author":"Krieger","year":"2009","journal-title":"Proteins"},{"issue":"3","key":"10.1016\/j.micpath.2025.107894_bib32","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/prot.10104","article-title":"Increasing the precision of comparative models with YASARA NOVA--a self-parameterizing force field","volume":"47","author":"Krieger","year":"2002","journal-title":"Proteins"},{"issue":"2","key":"10.1016\/j.micpath.2025.107894_bib33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jconrel.2010.03.027","article-title":"Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response","volume":"145","author":"Henriksen-Lacey","year":"2010","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.micpath.2025.107894_bib34","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.micpath.2019.01.045","article-title":"Mycobacterium tuberculosis Ag85b: hfc\u03b31 recombinant fusion protein as a selective receptor-dependent delivery system for antigen presentation","volume":"129","author":"Babaki","year":"2019","journal-title":"Microb. Pathog."},{"issue":"Suppl 1","key":"10.1016\/j.micpath.2025.107894_bib35","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.ijid.2023.03.035","article-title":"Tuberculosis vaccines update: is an RNA-based vaccine feasible for tuberculosis?","volume":"130","author":"Larsen","year":"2023","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2025.107894_bib36","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1080\/10717544.2022.2120565","article-title":"Nanomaterials in tuberculosis DNA vaccine delivery: historical perspective and current landscape","volume":"29","author":"Luo","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.micpath.2025.107894_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.cyto.2017.09.027","article-title":"Mycobacterium tuberculosis strains induce strain-specific cytokine and chemokine response in pulmonary epithelial cells","volume":"104","author":"Mvubu","year":"2018","journal-title":"Cytokine"},{"issue":"31","key":"10.1016\/j.micpath.2025.107894_bib38","doi-asserted-by":"crossref","first-page":"50415","DOI":"10.18632\/oncotarget.17304","article-title":"A single nucleotide polymorphism in the interferon-\u03b3 gene (IFNG +874 T\/A) is associated with susceptibility to tuberculosis","volume":"8","author":"Wei","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.micpath.2025.107894_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0003116","article-title":"Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements","volume":"3","author":"Agger","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.micpath.2025.107894_bib40","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3389\/fimmu.2020.01393","article-title":"Fc gamma receptors and their role in antigen uptake, presentation, and T cell activation","author":"Junker","year":"2020","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2025.107894_bib41","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.celrep.2017.09.034","article-title":"tuberculosis-initiated human mannose receptor signaling regulates macrophage recognition and vesicle trafficking by FcR\u03b3-Chain, Grb2, and SHP-1","volume":"21","author":"Rajaram","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.micpath.2025.107894_bib42","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3389\/fimmu.2017.01959","article-title":"Interleukin (IL)-23 stimulates IFN-gamma secretion by CD56(bright) natural killer cells and enhances IL-18-Driven dendritic cells activation","volume":"8","author":"Ziblat","year":"2017","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.micpath.2025.107894_bib43","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1038\/s41423-021-00658-z","article-title":"Recombinant vaccine containing an RBD-Fc fusion induced protection against SARS-CoV-2 in nonhuman primates and mice","volume":"18","author":"Sun","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"7830","key":"10.1016\/j.micpath.2025.107894_bib44","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-020-2599-8","article-title":"A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity","volume":"586","author":"Yang","year":"2020","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.micpath.2025.107894_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13246189","article-title":"Targeting cross-presentation as a route to improve the efficiency of peptide-based cancer vaccines","volume":"13","author":"Wylie","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.micpath.2025.107894_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115758","article-title":"Antigen cross-presentation in dendric cells: from bench to bedside","volume":"168","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.micpath.2025.107894_bib47","article-title":"Plant-produced N-glycosylated Ag85A exhibits enhanced vaccine efficacy against Mycobacterium tuberculosis HN878 through balanced multifunctional Th1 T cell immunity","volume":"8","author":"Kim","year":"2020","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.micpath.2025.107894_bib48","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1128\/CVI.00818-13","article-title":"Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians","volume":"21","author":"Ogunjimi","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"issue":"5512","key":"10.1016\/j.micpath.2025.107894_bib49","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1126\/science.291.5512.2370","article-title":"Glycosylation and the immune system","volume":"291","author":"Rudd","year":"2001","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.micpath.2025.107894_bib50","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/nri2417","article-title":"Mammalian glycosylation in immunity","volume":"8","author":"Marth","year":"2008","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.micpath.2025.107894_bib51","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1007\/s12010-023-04329-9","article-title":"Gene expression study of host and Mycobacterium tuberculosis interactions in the manifestation of acute tuberculosis","volume":"195","author":"Abbasnia","year":"2023","journal-title":"Appl. Biochem. Biotechnol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025006199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025006199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:54:44Z","timestamp":1777575284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025006199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":51,"alternative-id":["S0882401025006199"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107894","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhancing Mycobacterium tuberculosis-Ag85B immunogenicity by fusing with human Fc\u03b31 (Ag85B:hFc\u03b31)","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.107894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107894"}}